CELLEBRATE: An Adaptive, Two Stage, Double-Blind, Stratified, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontinence
The purpose of this study is to evaluate the safety and efficacy of muscle derived cells for bladder opening repair. Muscle cells will be harvested by thigh muscle biopsy from patients who suffer from stress urinary incontinence. The cells will be grown out until there is an adequate amount of cells and injected around the patient’s bladder opening with their own cells.
This study is actively recruiting women between the ages of 50-75 who suffer from stress urinary incontinence. Please email gynresearch@stanford.edu for more information.
Principal Investigator: Eric Sokol, MD
Lessening Incontinence through Low-impact Activity (LILA)
The purpose of the study is to examine the use of yoga and physical conditioning and effects it has in reducing episodes of both stress and urge incontinence in women. Participants will be randomized to either practice yoga or physical conditioning in virtual group sessions twice a week, for 12 weeks.
This study is actively recruiting women 45+ years old who suffer from stress urinary incontinence. Please email gynresearch@stanford.edu for more information.
Principal Investigator: Leslee Subak, MD
Randomized, Comparator-Controlled, Single Blinded, Multicenter Study Evaluating the Efficacy and Safety of Yōni.Fit® in Women with Stress Urinary Incontinence (SUI)
The purpose of this study is to evaluate the safety and effectiveness of Yōni.Fit® Test device compared to Yōni.Fit® Comparator device, in temporary management of stress urinary incontinence in women. The Yōni.Fit® Bladder Support is 100% medical grade silicone, collapsible device placed into the vagina to provide urinary continence. It has the distinct advantage of being minimally invasive and may provide immediate relief of the symptoms of stress urinary incontinence.
This study is actively recruiting adult women who suffer from stress urinary incontinence. Please email gynresearch@stanford.edu or visit LeakyLady.com for more information.
Principal Investigator: Eric Sokol, MD
Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder Symptoms
The purpose of this study is to evaluate the safety and effectiveness of the TheraNova Neuromodulation System at decreasing symptoms related to overactive bladder (OAB). The TheraNova Neuromodulation System is being developed as a non-invasive treatment similar to a TENS unit to reduce OAB symptoms and participation includes self-administering one 30-minute treatment three times per week for 12 weeks.
This study is actively recruiting adult women who suffer from overactive bladder (OAB) with urge urinary incontinence or mixed urinary incontinence. Please email gynresearch@stanford.edu for more information.
Principal Investigator: Eric Sokol, MD